UMedic has prospective earnings growth over the next two years


UMediC Group Bhd's manufacturing plant in Batu Kawan, Penang.

PETALING JAYA: Rakuten Trade Sdn Bhd has placed a “buy” call on medical device maker UMediC Group Bhd with a higher target price (TP) of 90 sen from 76 sen.

In a report, the research house said the fast growing distributor of medical equipment and manufacturer of medical consumables is backed by solid prospective earnings growth over the next two years.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
UMedic

Next In Business News

IJM looks to FY27 after tough fourth quarter
MM Computer retail IPO oversubscribed�
BCorp revenue at RM2.2bil in third quarter
Northern Solar unit secures RM47.5mil job
Malakoff targets steady recovery
Mudajaya unit sells 45% stake
Maybank stays on steady footing
Padini resilient despite softer consumer spending
IOIPG profit triples in 3Q26, reiterates outlook
US first-quarter GDP growth revised lower to 1.6% pace

Others Also Read